Basic Information | Post buying leads | Suppliers |
Name |
Cibenzoline succinate |
EINECS | N/A | ||||||
CAS No. | 100678-32-8 | Density | g/cm3 | ||||||
PSA | 98.99000 | LogP | 2.69450 | ||||||
Solubility | N/A | Melting Point |
165° |
||||||
Formula | C18H18N2.C4H6O4 | Boiling Point | 449.2°Cat760mmHg | ||||||
Molecular Weight | 380.44 | Flash Point | 225.5°C | ||||||
Transport Information | N/A | Appearance | N/A | ||||||
Safety |
|
Risk Codes | R22 | ||||||
Molecular Structure | Hazard Symbols | ||||||||
Synonyms |
2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole succinate |
IUPAC Name: Butanedioic acid; 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
Canonical SMILES: C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4.C(CC(=O)O)C(=O)O
InChI: InChI=1S/C18H18N2.C4H6O4/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17;5-3(6)1-2-4(7)8/h1-10,16H,11-13H2,(H,19,20);1-2H2,(H,5,6)(H,7,8)
InChIKey: XFUIOIWYMHEPIE-UHFFFAOYSA-N
Molecular Weight: 380.43696 [g/mol]
Molecular Formula: C22H24N2O4
H-Bond Donor: 3
H-Bond Acceptor: 6
EINECS: 260-856-8
Product Categories: Heterocyclic Compounds
storage temp.: 2-8 °C
Flash Point: 225.5 °C
Enthalpy of Vaporization: 68.06 kJ/mol
Boiling Point: 449.2 °C at 760 mmHg
Vapour Pressure: 7.75E-08 mmHg at 25 °C
Classification Code of Cibenzoline succinate (CAS NO.100678-32-8): Cardiac depressant [anti-arrhythmic]; Drug / Therapeutic Agent; Reproductive Effect
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
dog | LD | oral | > 56mg/kg (56mg/kg) | BEHAVIORAL: TREMOR | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4519, 1988. |
dog | LD50 | intravenous | 33300ug/kg (33.3mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 25, Pg. 3385, 1991. |
mouse | LD50 | intraperitoneal | 73100ug/kg (73.1mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
mouse | LD50 | oral | 180mg/kg (180mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
mouse | LD50 | subcutaneous | 83300ug/kg (83.3mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
rat | LD50 | intraperitoneal | 83400ug/kg (83.4mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
rat | LD50 | intravenous | 44400ug/kg (44.4mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
rat | LD50 | oral | 359mg/kg (359mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
rat | LD50 | subcutaneous | 156mg/kg (156mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988. |
Hazard Codes: Xn
Risk Statements: 22
R22:Harmful if swallowed.
RTECS of Cibenzoline succinate (CAS NO.100678-32-8): EJ9960100
Cibenzoline succinate (CAS NO.100678-32-8), its Synonyms are (+-)-2-(2,2-Diphenylcyclopropyl)-2-imidazoline succinate (1:1) ; 1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+-)-, butanedioate (1:1) ; 1H-Imidazole, 4,5-dihydro-2-(2,2-diphenylcyclopropyl)-, succinate ; 4,5-Dihydro-2-(2,2-diphenylcyclopropyl)-1H-imidazole succinate ; Cibenzoline succinate (1:1) ; Cipralan ; Ritmalan ; Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:1) .